These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4948095)

  • 41. Thalidomide--the story goes on...
    Learned J
    Notes Undergr; 1998; (No 37):1, 7, 9. PubMed ID: 11365815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Further observations on the use of thalidomide in leprous "reactions"].
    Trimigliozzi G
    G Ital Dermatol Minerva Dermatol; 1967; 108(3):223-8. PubMed ID: 5632577
    [No Abstract]   [Full Text] [Related]  

  • 43. Thalidomide in lepra reaction.
    Sheskin J
    Int J Dermatol; 1975 Oct; 14(8):575-6. PubMed ID: 1176243
    [No Abstract]   [Full Text] [Related]  

  • 44. Study with nine thalidomide derivatives in the lepra reaction.
    Sheskin J
    Int J Dermatol; 1978; 17(1):82-4. PubMed ID: 627447
    [No Abstract]   [Full Text] [Related]  

  • 45. [Supidimide, a non-teratogenic thalidomide analog for the treatment of leprosy reaction?].
    Sheskin J; Mückter H; Frankus E
    Hautarzt; 1983 Apr; 34(4):168-70. PubMed ID: 6853166
    [No Abstract]   [Full Text] [Related]  

  • 46. [Thalidomide in the control of pain in leprotic neuritis].
    Belda W; Manzoli S; Jordy CF
    Hospital (Rio J); 1966 Sep; 70(3):731-7. PubMed ID: 5300280
    [No Abstract]   [Full Text] [Related]  

  • 47. Effectiveness of Methotrexate in prednisolone and thalidomide resistant cases of Type 2 lepra reaction: report on three cases.
    Rahul N; Sanjay KS; Singh S
    Lepr Rev; 2015 Dec; 86(4):379-82. PubMed ID: 26964434
    [No Abstract]   [Full Text] [Related]  

  • 48. Open trial with clofazimine in the management of recurrent lepra reaction and of sulphone sensitive cases: a preliminary report.
    Ramanujam K; Iyer CG; Ramu G
    Lepr Rev; 1975 Jun; 46(2 Suppl):117-20. PubMed ID: 1100950
    [No Abstract]   [Full Text] [Related]  

  • 49. Complement and immunoglobulin determinations in leprosy and lepra reaction.
    Sagher F; Sheskin J; Zlotnick A; Turk JL
    Int J Lepr Other Mycobact Dis; 1971; 39(2):541-53. PubMed ID: 5169814
    [No Abstract]   [Full Text] [Related]  

  • 50. Letter: Use of drugs and their effects on leprosy patients.
    Graver V
    Int J Lepr Other Mycobact Dis; 1974; 42(1):72. PubMed ID: 4472185
    [No Abstract]   [Full Text] [Related]  

  • 51. Iron content of skin before and after thalidomide treatment of lepra reaction. A preliminary report.
    Sheskin J; Gorodetsky R; Weinreb A; Loewinger E
    Dermatologica; 1981; 163(2):145-50. PubMed ID: 7286355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Rapidly resolutive action of thalidomide on recurrences of leprosy].
    Degos R; Lortat-Jacob E; Civatte J; Daniel F
    Bull Soc Fr Dermatol Syphiligr; 1966; 73(5):474-8. PubMed ID: 5987422
    [No Abstract]   [Full Text] [Related]  

  • 53. [Comparative study of the therapeutic activity of glutamic acid phthalimide and the therapeutic activity of triamcinolone in the treatment of Hansen's reaction of Virchowian Leprosy].
    de Almeida Neto E
    Hansenol Int; 1981 Dec; 6(2):114-21. PubMed ID: 6759397
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of thalidomide in the management of erythema nodosum leprosum.
    Walker SL; Waters MF; Lockwood DN
    Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Supplies of thalidomide for use in leprosy.
    Loretti A; Barchi E
    Lepr Rev; 1986 Mar; 57(1):76-7. PubMed ID: 3702585
    [No Abstract]   [Full Text] [Related]  

  • 56. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
    Naafs B
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120
    [No Abstract]   [Full Text] [Related]  

  • 57. Treatment of leprosy: science or politics?
    Naafs B
    Trop Med Int Health; 2006 Mar; 11(3):268-78. PubMed ID: 16553906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical evaluation studies in lepromatous leprosy. Sixth series: effect (on lepra reaction) of supplementing DDS with dexamethasone, methandrostenolone, or mefenamic acid.
    Doull JA; Tolentino JG; Guinto RS; Rodriguez JN; Leano LM; Fernandez JV; Rivera JN; Fajardo TT
    Int J Lepr Other Mycobact Dis; 1967; 35(2):128-39. PubMed ID: 5338957
    [No Abstract]   [Full Text] [Related]  

  • 59. Response to treatment by multidrug regimens in the THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Lepr Rev; 1996 Dec; 67(4):260-79. PubMed ID: 9033197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trials with thalidomide derivatives in leprosy reactions.
    Sheskin J; Sagher F
    Lepr Rev; 1968 Oct; 39(4):203-5. PubMed ID: 5722496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.